|
Apheresis News is committed to providing valuable information and resources to the apheresis community and has collaborated with reputable organizations to offer the following industry-related products. If your organization is interested in partnering with Apheresis News to distribute products, please email info@apheresisnews.com.
____________________________________________________________________________

Published November 2005. Print Copy ($3950)
Report Highlights
-
Sales for the blood and blood components segment and the plasma derived segment of the U.S. blood market will approach $6.6 billion in 2005 and are expected to approach $9.9 billion in 2010, rising at an average annual growth rate (AAGR) of 8.5%.
-
The collection and processing products segment will grow from over $1.8 billion to nearly $2.5 billion at an AAGR of 7%.
-
The driving forces of the industry are collection and processing cost, technology, an aging population and the changes in the incidence of diseases, surgical procedures and catastrophes that require transfusions.
-
Safety of the blood supply is the primary issue and donation testing has been enhanced with the greater use of nuclear amplifications testing methods.
Click here for further information or use the navigation to the left.
|